Calponin reduces shortening velocity in skinned taenia coli smooth muscle fibres  by Jaworowski, Åsa et al.
FEBS 15523 FEBS Letters 365 (1995) 167-171 
Calponin reduces shortening velocity in skinned taenia coli 
smooth muscle fibres 
Asa Jaworowski a, Kurt I. Anderson b, Anders Arner a'*, Martin Engstr6m a, Mario Gimonab'% 
Peter Strasser b, J. Victor Small b 
aDepartment of Physiology and Biophysics, Lund University, S6lvegatan 19, S-223 62 Lund, Sweden 
blnstitute of Molecular Biology, Austrian Academy of Sciences, Salzburg, Austria 
CCold Spring Harbor Laboratory, CoM Spring Harbor, New York, USA 
Received 11 April 1995 
Abstract Calponin (4.1-5.9/.tM, pig stomach) inhibited maxi- 
mal shortening velocity (Vm,x) by 20-25% with only minor influ- 
ence on force in skinned smooth muscle from guinea-pig taenia 
coli activated at different Ca 2+ levels and with thiophosphoryla- 
tion. Similar results were obtained with a fragment of the N- 
terminal 1-228 amino acids engineered using a mouse cDNA 
construct (5.4 pM). Both the native calponin and the fragment 
inhibited actin filament sliding in a graded manner in an in vitro 
motility assay. We conclude that calponin influences the kinetics 
of the actin-myosin interaction in the organised smooth muscle 
contractile system and that engineered fragments of calponin can 
be used to probe its action in muscle fibres. The effects can be 
due to an introduction of an internal load during filament sliding, 
possibly by decreasing the detachment rates and increasing the 
cross-bridge time spent in the attached state. 
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1. Introduction 
The inhibition of the actomyosin/Mg-ATPase activity can be 
reversed by Ca2*-calmodulin [13] or calcium-caltropin [15] and 
by phosphorylation f calponin [12]. The role of these regula- 
tory mechanisms in vivo is, however, unknown and in part also 
controversial [8,16,17,18,19]. 
Whereas the in vitro inhibitory effects of calponin on acto- 
myosin/ATPase activity are well documented, information re- 
garding its effects on the organised contractile system is sparse. 
Itoh et al. [20] recently reported that exogenously added 
calponin reduced active tension in smooth muscle. In this re- 
port we describe the application of native calponin as well as 
a recently engineered fragment of the molecule [15] to chemi- 
cally skinned taenia coli muscles activated by calcium or thio- 
phosphorylation. The activity of the protein preparations was 
also assayed in parallel in actin filament sliding assays, which 
have formerly shown the inhibitory effects of calponin on fila- 
ment velocity [21,22]. Our results how that the maximal short- 
ening velocity (Vmax) is inhibited to a larger extent han force 
by calponin which might reflect an introduction of an internal 
load during filament sliding, possibly by slowing cross-bridge 
detachment reactions. 
Calponin, a 34 kDa protein first isolated from chicken giz- 
zard and bovine aortic smooth muscle [1,2], has been proposed 
to be a regulatory protein involved in smooth muscle contrac- 
tion. Calponin binds in vitro to a variety of proteins including 
actin, tropomyosin, calmodulin and myosin [1,2,3,4]. In smooth 
muscle cells the protein is found to be associated with the actin 
filaments [5,6]. In native thin filaments calponin:actin ratios of 
about 1 : 10 16 have been reported [7,8]. The interaction with 
other thin filament proteins is not clarified at present but bind- 
ing studies have suggested that calponin and caldesmon com- 
pete for the same binding site on actin [9], raising the possibility 
that these proteins are associated with different classes of thin 
filaments [10]. Recent immunocytochemistry of chicken gizzard 
smooth muscle [11] has revealed that, whereas caldesmon is
co-localised with the contractile proteins, calponin is associated 
with both the contractile and cytoskeletal proteins. 
In vitro calponin inhibits actin-activated myosin Mg-ATPase 
activity [12,13], reportedly via a predominant effect on the Vmax 
of the ATPase with only a minor effect on the Km [7,14]. The 
inhibitory action of calponin is not due to an inhibitory effect 
on myosin phosphorylation [12,13] and is not dependent on the 
presence of tropomyosin [12], although an interaction between 
these proteins may occur due to co-operative phenomena [14]. 
*Corresponding author. Fax: (46) (46) 10-4546. 
2. Materials and methods 
2.1. Muscle preparation and solutions 
Taenia coli preparations were obtained from guinea-pigs (300400 
g). The animals were killed by cervical dislocation and the muscles were 
dissected and immediately skinned with Triton X-100 as earlier de- 
scribed [23]. The preparations were stored in a glycerol solution at 
-15°C until the experiments were performed. Thin preparations (5 7 
mm long and with diameter 0.14).2 mm) were cut out and mounted as 
described below. 
Solutions contained 30 mM N-tris-(hydroxymethyl)methyl-2-ami- 
noethane-sulfonic acid (TES), 2 mM Mg 2+, 3.2 mM Mg-ATP, 12 mM 
phosphocreatine (PCr), 0.5 mg/ml creatine kinase (CK), 4 mM ethylene 
glycol-bis(fl-aminoethyl ether)N.N,N'N'-tetraacetic acid (EGTA), 1 
mM NaN3 and 0.5/xM calmodulin. In the relaxation solutions free 
[Ca  z÷] was  10 -9 M (pCa 9.0) and in the contraction solutions 10 -45 M 
(pCa 4.5). The contraction and relaxation solutions were mixed in 
appropriate amounts to obtain intermediate [Ca2÷]. The rigor solutions 
were made without Mg-ATP, PCr and CK. Thiophosphorylation was 
performed ina rigor solution with pCa 4.5, 1 mM ATP-~'-S and 0.5pM 
calmodulin. The ionic strength of all solutions was 150 mM adjusted 
with KC1 and pH was 6.9 adjusted with KOH. Calponin and the CP 
1-228 fragment, when added, were introduced from a stock solution in 
TES as described below. The composition ofthe solutions were calcu- 
lated as described in [24]. 
Pig stomach calponin was purified according to Vancompernolle et 
al. [25] and lyophilised. Prior to experiments, calponin was dissolved 
and dialysed for 2 or 12 h at 4°C against 20 mM TES at pH 6.9. This 
calponin stock solution was used to mix experimental solutions. The 
dialysis medium served as control solution. The calponin concentration 
was determined in the experimental solutions according to the Brad- 
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ford-method, using bovine serum albumin as a standard, or in the 
calponin stock solution by measuring the optical density at 276 nm 
(using an extinction coefficient, E1%276 nm, of 8.9). A molecular weight 
for calponin of 33 kDa was used. The N-terminal fragment CP 1-228 
was engineered in bacteria using a mouse cDNA construct as described 
previously [I5]. An extinction coefficient, El%276nm, of 7.7 and a molec- 
ular weight of 25 kDa were used. The fragment was dialysed prior to 
experiments a  described above for calponin [15]. 
2.2. Isotonic quick release experiments 
Force-velocity relationships were determined as described by [23] 
with the preparations mounted in an apparatus with an AE 801 force 
transducer (SensoNor a.s., Horten, Norway) and an isotonic lever. The 
muscles were mounted in relaxing solution at a passive load of about 
0.1 mN. Force-velocity relations were determined in fibres activated 
with Ca 2÷ or with irreversible thiophosphorylation f the regulatory 
myosin light chains. A series of 15 25 releases to different afterloads 
was performed at the force plateau of contractions. The shortening 
velocity (V) was determined 100 and 500 ms after the release and then 
fitted to the Hill force-velocity equation in the form V = b(1 - P/P0)/(P/ 
P0 + a/P0); where a and b = constants, P = afterload and P0 -- isometric 
force. In fibres activated with Ca 2÷, the experimental protocol con- 
tained an initial 5 min period in relaxation solution followed by activa- 
tion with a calponin-free solution at pCa 4.5 for 30 min. At the plateau 
of this control contraction a first series of quick releases was performed. 
The fibre preparation was relaxed for 10 min and thereafter contracted 
in either calponin-free or calponin-containing solution at intermediate 
[Ca2+], pCa 5.75, for 30 min before performing another series of quick 
releases. Then the muscle was transferred tocontraction solution with 
pCa 4.5 with or without calponin and at the plateau of the contraction 
a third series of quick releases was performed. In each fibre preparation, 
both the second and the third contractions were performed in the same 
kind of solution (either calponin-free or calponin-containing). Force 
and the maximal shortening velocity (Vm,x) for the second (pCa 5.75) 
and the third contraction (pCa 4.5) were expressed relative to those 
during the initial control contraction i calponin-free solution obtained 
in each preparation. 
In experiments on thiophosphorylated preparations the muscles were 
mounted in relaxation solution as described above and then exposed 
to a repeated thiophosphorylation protocol as described in [26]. The 
preparations were treated with the thiophosphorylation solution for 15 
min and then transferred to a rigor solution for 5 min before each 
contraction. The muscles were contracted by transfer to ATP-, PCr-and 
CK-containing solution with pCa 9.0 (i.e. the relaxation solution 
above). Four contractions, each preceded by a thiophosphorylation 
period, were performed on each fibre preparation. The first two con- 
tractions were elicited in calponin-free solutions, the third contraction 
in either calponin-free or calponin-containing solution and the fourth 
contraction i  a calponin-free solution. During the second, third and 
fourth contractions quick releases were performed after 30 min. The 
maximal shortening velocities and force were expressed relative to those 
during the second control contraction. Experiments on the CP 1-228 
fragment on thiophosphorylated fibres were performed as described 
above, except hat calponin was replaced by the fragment. 
2.3. In vitro motility assays 
Avian smooth muscle actin was purified according to [27]. Rabbit 
skeletal muscle myosin was prepared by a procedure modified from 
[28], and HMM made from fresh myosin according to [29]. HMM was 
aliquoted, frozen in liquid nitrogen and stored at -70 °. HMM prepared 
in this way exhibited activity after thawing comparable tofresh HMM. 
The in vitro motility assay was performed at 36°C essentially accord- 
ing to [30] with the following variations: after actin had bound to the 
immobilised HMM on the glass surface, calponin or the CP 1 228 
fragment in assay buffer (containing 4 mM MgCI 2, 1 mM EGTA, 80 
mM KC1 and 25 mM imidazole with pH 7.4) was perfused into the 
chamber and allowed to bind to actin. Perfusion was then continued 
with the same mixture supplemented with 1 mM Mg-ATP and 0.6% 
methyl cellulose, 30 s was allowed for equilibration within the chamber, 
then three separate fields were recorded for 20 s each using a Sony 
Umatic VO-5800PS video recorder. Actin filament velocity analysis was 
performed on a Macintosh Quadra 650 computer using a macro pro- 
gram for tracking (written by Kurt Anderson) which runs under NIH 
Image (written by Wayne Rasband at the US National Institutes of 
Health, and available from the Internet by anonymous ftp from 
zippy.nimh.nih.gov or on floppy disk from NTIS, 5285 Port Royal Rd. 
Springfield, VA 22161 part number PB93-504868). All of the filaments 
were tracked in a given twenty second series. For all points more than 
20 filaments were tracked, except for the slowest velocities, where 10 
filaments were tracked. The optimal ratio of HMM, actin and methyl 
cellulose for the maximum velocit i and minimal filament shredding was 
determined in control experiments and held constant throughout. 
2.4. Statistics 
Results are given as mean + S.E.M. with the number of observations 
given within parenthesis. Statistical comparisons were made according 
to the Student's t-test for unpaired data and with the Bonferroni 
method when more than two means were compared. 
3. Results 
Both intact calponin and the engineered fragment composed 
of amino acids 1-228 produced a dose-dependent i hibit ion of 
the velocity of movement of smooth muscle actin filaments over 
skeletal muscle HMM.  Velocity histograms showed that 
calponin caused a dose-dependent shift in the velocity distribu- 
tion towards lower velocities rather than introducing a popula- 
tion of non-moving filaments. This suggests that the effects 
occurred gradually, rather than in an all-or-none fashion. In 
Fig. 1 the mean velocity is plotted against concentrat ion of 
calponin and CP 1-228. A complete arrest of movement was 
observed at about 0.5/.tM for calponin and 1.5 ¢tM for the CP 
1-228 fragment. 
Fig. 2 shows the maximal shortening velocity (Vmax) at 100 
ms plotted against the isometric force at different activation 
levels. Force and velocity data are expressed relative to those 
during the initial control contract ion in each fibre (the cross in 
Fig. 2 indicates this point with Vmax and force -- 1). Open sym- 
bols show data obtained in the absence of calponin. Intermedi- 
ate activation by pCa 5.75 (open circle) was associated with 
lower force and Vma X compared to pCa 4.5 (open square). The 
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Fig. 1. Inhibitory effect of mcreasing concentrations (tiM) of native 
calponin (filled diamonds) and the N-terminal CP 1-228 fragment (filled 
triangles) on the mean velocity of smooth muscle actin filaments over 
skeletal HMM. Control velocities obtained in the absence of calponin 
and the fragment are shown with open symbols. 
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force-velocity relation obtained uring the contraction in pCa 
4.5 (open square) was similar to that obtained uring the initial 
control contraction (cross) showing that no irreversible altera- 
tions in mechanical behaviour occurred uring the experiment. 
Calponin, (4.1 + 0.3 ¢tM, n = 5) significantly decreased Vmax in 
both maximally and submaximally activated fibres (filled circle: 
pCa 5.75, P < 0.01 and filled square: pCa 4.5, P < 0.001) with- 
out affecting the isometric force. Table 1 shows the average 
force and maximal shortening velocity (Vmax) in absolute units 
(muscle lengths per s) as well as the parameters b and aiPo of 
the Hill force-velocity equation. In accordance with earlier 
studies [23], we chose to measure velocity at 100 ms after re- 
lease. The Vmax at 500 ms after release are also given in Table 
1. Since velocity at this point in time was decreased by calponin 
at pCa 4.5, the influence of calponin on the shortening velocity 
was not restricted to the initial shortening phase after the re- 
lease. The decrease in Vmax was associated with a small increase 
in b and an increase in alPo which shows that the force-velocity 
relation had become less concave in the presence of calponin. 
Force-velocity data obtained in thiophosphorylated muscles 
are inserted in Fig. 2 (diamonds and triangle). In these maxi- 
mally activated preparations calponin (5.9 + 0.8 /zM, n = 5, 
filled diamond) caused a significant (P< 0.01, Bonferroni 
method) reduction in Vm~x compared to the thiophosphorylated 
muscle in the absence of calponin (open diamond). The de- 
crease was of the same magnitude as in the calcium activated 
muscles, In addition, a small (about 10%) but significant de- 
crease of force (P < 0.01, Bonferroni method) was observed 
compared to the thiophosphorylated muscle in the absence of 
calponin (open diamond). Velocity in muscle lengths per second 
at 500 ms was lower although not significantly (Table 1). When 
expressed relative to the control velocity at 500 ms obtained in 
each fibre the Vmax at 500 ms, was significantly reduced in the 
presence of calponin (0.66 _+ 0.05) compared to the controls 
(0.92 + 0.08, P < 0.05). 
Force-velocity data obtained in the presence of the CP 1-228 
fragment (5.4 + 1.2 ¢tM, n = 5, filled triangle in Fig. 2) revealed 
a significant reduction in Vmax of the same magnitude (P < 0.05, 
Bonferroni method) as that observed for the native calponin 
and a small reduction in active force. Force velocity data in 
absolute units are shown in Table 1. 
4. Discussion 
Calponin caused a pronounced inhibition of the maximal 
shortening velocity of the skinned smooth muscle fibres with 
a minor influence on force. Since the effect on velocity was 
observed in both calcium activated and thiophosphorylated 
fibres, we consider it to be due to a direct effect of calponin on 
the actin-myosin interaction, rather than to an influence on 
myosin phosphorylation, which is consistent with previous bio- 
chemical studies [12]. In smooth muscle fibres, variations in 
[Ca 2+] and myosin light chain phosphorylation i fluence both 
force and Vm~ x ([24,31], Fig. 2 and Table 1). The modulation 
of the force velocity relation by calponin appears to be differ- 
ent from that caused by variations in [Ca 2÷] and phosphoryla- 
tion since calponin causes a reduction in V, nax with only a minor 
influence on force. Also, the influence on the shape of the force 
velocity relation appears to be different; a reduction in Vma x by 
lowering [Ca 2+] is associated with a reduction in the parameter 
b whereas calponin addition causes a small increase in b and 
an increase in a/Po reflecting a less concave relationship. A
change in the a/Po parameter can be considered to reflect a 
change in the ratio between the number of cross-bridges exert- 
ing positive and the number of cross-bridges exerting negative 
force [32]. Since Vma x is considered to be rate limited by cross- 
bridge detachment reactions [32] the inhibition of Vmax by 
calponin could be due to a slowing of product release steps 
leading to an increase in the time the cross-bridges spend in 
attached states, introducing an internal load by increasing the 
number of cross-bridges xerting negative force during shorten- 
ing. An influence on product release steps is consistent with 
results of biochemical studies howing that calponin influences 
catalytical reactions rather than the actin-myosin binding 
[7,14]. However, since calponin also seems to be associated with 
the cytoskeleton i  the smooth muscle cells [11] a structural 
change in this cellular domain introduced by calponin influenc- 
ing filament sliding might also be involved. 
The small decrease in force observed in the thio- 
phosphorylated fibres could be due to the somewhat higher 
concentration of calponin in those experiments (5.9 /IM in 
comparison with 4.1/zM). One possibility is that calponin re- 
duces cross-bridge cycling leading to a longer occupancy in 
Table 1 
Effects of calponin and the CP 1-228 fragment on force-velocity characteristics atdifferent levels of activation with calcium or after thiophosphoryla- 
tion Isometric force (P0), relative to that during an initial control contraction, Vm,x in muscle lengths (ML) per s measured at 100 ms and 500 ms 
after elease and the parameters b and a/Po at 100 ms after elease are shown. Significant differences between the calponin/fragment- and the respective 
calponin/fragment-free groups are indicated (Student's t-test for the Ca 2÷ activated and the Bonferroni method for thiophosphorylated group). 
Concentrations of calponin and CP 1-228 are given in section 3. 
Po V . . . .  100 ms b, 100 ms a/Po, 100 ms V ..... 500 ms 
(ME/s) (ME/s) (ML/s) 
pCa 5.75 (n = 5) 0.68 _+ 0.07 0.144 + 0.014 0.013 + 0.005 0.094 _.% 0.043 
pCa 5.75 + calponin (n = 5) 0.75 + 0.06 0.122 +_ 0.018 0.026 + 0.003 0.224 ± 0.018 
p < 0.05 p < 0.05 
pCa 4.5 (n = 5) 1.00 + 0.06 0.172 + 0.008 0.019 + 0.006 0.116 + 0.041 
pCa 4.5 + calponin (n = 5) 1.07 -+ 0.08 0.135 _+ 0.013 0.030 _+ 0.010 0.214 + 0.060 
p < 0.05 
Thiophos. (n = 6) 0.96 + 0.01 0.152 + 0.014 0.014 + 0.002 0.097 + 0.019 
Thiophos. + calponin (n = 6) 0.86 + 0.02 0.115 + 0.012 0.016 + 0.003 0.150 ± 0.045 
p < 0.01 
Thiophos. + CP 1-228 (n = 5) 0.90 + 0.03 0.113 + 0.009 0.031 _+ 0.005 0.280 ± 0.047 
p < 0.05 p < 0.05 p < 0.01 
0.043 + 0.007 
0.049 _+ 0.008 
0.052 + 0.005 
0.039 + 0.005 
p < 0.05 
0.063 + 0~003 
0.055 + 0.008 
0.041 + 0,003 
p < 0.05 
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Fig. 2. Relation between maximal shortening velocity (Vm,x) and iso- 
metric force at different levels of activation i  the absence (open sym- 
bols) and in the presence ofcalponin (filled circle, square and diamond) 
or the CP 1-228 fragment (filled triangle). The preparations were either 
activated at pCa 5.75 (circles), at pCa 4.5 (squares) or irreversibly 
thiophosphorylated (diamonds, triangle). All force and Vmax values of 
calcium activated and thiophosphorylated preparations are normalised 
relative to those obtained uring the respective initial control contrac- 
tions (cross, relative force and Vm,x = 1). n ---- 5-10. 
attached states as discussed above. An increased number of 
attached heads, in the presence of calponin, might coopera- 
tively turn on the actin filament as suggested by Horiuchi and 
Chacko [14]. If the thin filament system is not cooperatively 
turned on in the calcium activated muscles to the same extent 
as in the thiophosphorylated fibres, a slowing of the cross- 
bridge cycle might have different influence on the force in these 
two types of activation. 
In a previous report on the effects ofcalponin on saponin and 
fl-escin skinned smooth muscle asubstantial depression offorce 
in the presence of calponin (about 25% inhibition by 5.6/.tM) 
was found [20] which is larger than the influence on force 
observed in the present study. We have at present no detailed 
information regarding the concentration dependence of the me- 
chanical effects ofcalponin or the fragment. Although Vma x was 
affected to a much larger extent han force for the protein 
concentrations wecould obtain in the present study it is possi- 
ble that higher protein concentrations might also influence 
force generation. In our study an average inhibition of force of 
10% was observed at 5.9/.tM calponin in thiophosphorylated 
muscles and no effect was noted at 4.1/tM calponin after Ca 2+ 
activation (Table 1). The difference between studies could re- 
flect differences in the skinning methods or smooth muscle fibre 
preparations u ed (rabbit blood vessels vs. guinea pig intestinal 
muscle, possibly containing different composition of thin fila- 
ments) or the source of calponin (avian from chicken gizzard 
vs. mammalian from pig stomach). 
In conclusion, our results regarding the effects of calponin 
on the mechanics of smooth muscle fibre preparations are in 
general agreement with data obtained from in vitro motility 
assay studies. Both Shirinsky et al. [21] and Haeberle [22] 
describe an inhibition of filament movement by calponin in the 
micromolar range which is similar to that obtained in the pres- 
ent study. The N-terminal fragment from the 1-228 mouse 
sequence was active at slightly higher concentrations, showing 
that the effect of the native protein can be mimicked by this 
truncated form containing proposed binding regions for actin, 
calcium binding proteins and tropomyosin (cf. [33]). The study 
of Shirinsky et al. [21] suggested that the inhibition of motility 
by calponin occurred in an all-or-none fashion. Our motility 
data suggest, however, a graded action of calponin and the 
fragment, although with a steep concentration dependence. The 
force and Vma~ of the smooth muscle fibre preparation reflects 
the behaviour of a large population of contractile filaments and 
a switch-like inhibition, as opposed to a graded inhibition, 
cannot be distinguished. The inhibition of Vm,x and the small 
effect on force are consistent with the inhibition of the dissoci- 
ation of the high-affinity actomyosin complex proposed by 
Haeberle [22]. Since our data are based on experiments where 
calponin is introduced to a contractile apparatus already con- 
taining endogenous calponin the exact nature of its regulatory 
role in the intact issue awaits further studies. Our data show, 
however, that calponin can act as a modulator of cross-bridge 
turnover kinetics in smooth muscle fibre preparations and that 
engineered calponin fragments can be used for probing its ac- 
tion in in vitro motility assays and in smooth muscle fibres. 
In a recent preliminary report [34], independent of our study, 
an inhibition of unloaded shortening velocity by calponin is 
described which is similar to some of the results of the present 
study. 
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